HOUSTON, June 8, 2017 /PRNewswire/ -- The Texas Medical Center (TMC) Innovation Institute today will host TMCx Demo Day to showcase its largest class of companies in the history of the accelerator, with 21 startups graduating from the four-month intensive program. During TMCx Demo Day, the companies will pitch their product and provide an update on future plans to a crowd expected to exceed 600 investors, hospital stakeholders, advisors and members of the innovation ecosystem.
The current TMCx cohort includes startups with digital health solutions in key health care areas, including artificial intelligence, medication management, health care process improvement, remote care and behavior/neurological health. In fall 2016, more than 300 companies competed for acceptance into TMCx, and almost 20 percent of those startups hailed from Silicon Valley, Calif. The fourth class of companies also includes three Australian companies from the TMC's new BioBridge health technology startup exchange program designed to create a global health ecosystem linking the United States and Australia.
"We are blown away by this cohort's progress and the traction these startups are getting with the 21 hospitals within the Texas Medical Center," said Erik Halvorsen, Ph.D., director of the TMC Innovation Institute. "The fourth class of companies has raised more VC funding than any previous class, and many of these companies are graduating today with agreements in place to test their products and applications at TMC hospitals. The TMCx accelerator lowers the barriers of access to hospital stakeholders and decisionmakers, and there's no question this class is poised for enormous success in making it to market."
Throughout the four-month program, the TMCx participant companies logged:
- 522 customer engagements with advisors, clinicians, investors and key opinion leaders to refine their company's value proposition and determine their product/market fit;
- 100 hours of intensive entrepreneurship curriculum, including engaging with hospital stakeholders, financial modeling and protecting intellectual property;
- 82 pilots, contracts, agreements or strategic partnerships started or completed; and
- Raised more than $44 million in total funding.
TMCx Demo Day will be livestreamed for people who want to tune in from another location. Companies completing the fourth TMCx program include:
- Arterys (San Francisco) – Automated, intelligent software that unleashes real-world clinical data to make imaging more accurate and data driven.
- Babyscripts (Washington, D.C.) – Remote monitoring to better identify high-risk pregnancies.
- CNSDose (Melbourne, Australia) – Genomic solution to fast-track finding the right antidepressant.
- ConsultLink (Houston) – Mobile workspace for care-team members to streamline and improve patient care.
- DOT (Ottawa, Canada) – Precise and effective wearable consumer devices that diagnose and treat neurobehavioral disorders.
- Glidian (Palo Alto, Calif.) – Electronic portal streamlining prior authorizations for medications and procedures.
- Healthcoin (Portland, Ore.) – Block chain-based incentives and data platform for diabetes prevention.
- InContext Reporting (Houston) – Quality management and clinical decision support tools powered by cognitive computing.
- Insight Rx (San Francisco) – Quantitative pharmacology and machine learning enabled precision medicine platform.
- Lantern (San Francisco) – Revolutionizing the delivery and efficacy of mental health services.
- M&S Biotics (Scranton, Pa.) – Artificial Intelligence and RFID technology improve resource utilization and efficiency.
- ManageUP PRM (Santa Clara, Calif.) – Communication and collaboration solution to improve the ability to deliver quality patient care.
- Medable (Palo Alto, Calif.) – Fast path to mobile for clinical care and medical research.
- Medifies (San Francisco) – Helping health providers communicate with families of patients in their care.
- NeuroLex Laboratories (Atlanta) – Voice analysis platform to detect health conditions before advanced symptoms appear.
- Personify Care (Adelaide, Australia) – Mobile platform enabling clinical teams to monitor patient recovery beyond the hospital stay.
- Psious (Barcelona, Spain) – Virtual reality immersion therapy for mental health disorders.
- SensorRx (Houston) – Patient-centered application to improve outcomes for migraine sufferers.
- Stroll Health (San Francisco) – Electronic Health Record-integrated referral platform.
- Vios Medical (Minneapolis and Bangalore, India) – Patient management information systems focusing on clinical workflow automation and remote patient care services.
- Ward Medication Management (Melbourne, Australia) – Decision support analytics engine providing evidence-based prescribing recommendations.
TMCx couples the resources of the world's largest medical center with the innovative spark of entrepreneurs to provide a comprehensive and practical curriculum for participating founders. Successful investors, entrepreneurs, subject-matter experts, industry professionals and hospital leaders guide each startup in the areas of intellectual property, product development, regulatory strategies, health policy, marketing, fundraising, contract negotiations and communications.
Applications are open until June 20 for the upcoming TMCx accelerator program focused on medical devices, which will run from Aug. 7 to Nov. 16, 2017. More information is available online.
TMCx is the Texas Medical Center's accelerator program housed in a 100,000-square-foot, state-of-the-art facility, designed to catapult the development of early-stage life science and digital health startups. TMCx is one of the core components of the Texas Medical Center's Innovation Institute and the first step in the Texas Medical Center's long-term plans to become one of the world's premiere life science commercialization clusters. TMCx provides entrepreneurs the essential resources for growth including office and meeting space, training curriculum and an extensive advisor network comprised of business and legal experts, health care professionals, executives and investors. The inaugural TMCx program launched in spring 2015. The Innovation Institute programs also include the TMC Biodesign fellowship and TMCx+ incubator. Corporate residents include Johnson & Johnson Innovation's JLABS @ TMC and AT&T Foundry for Connected Health, as well as a partnership with Apple. For more information, visit www.tmcinnovation.org.
Vice President of Communications
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tmcx-graduates-largest-class-of-startups-in-accelerator-program-300471213.html
SOURCE Texas Medical Center